By continuing to browse the site you are agreeing to our use of cookies and similar tracking technologies described in our privacy policy.

Search

Resource Library

Home
Test, Evaluate, Monitor
Treatment-Naive
Treatment-Experienced Patients
Unique & Key Populations
About

Resource Library

Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1

Journal

N Engl J Med

Year of Publication

2015

Volume

373

Issue

8

Pagination

714-725

Authors

D Wyles
P Ruane
M Sulkowski
D. Dieterich
A. Luetkemeyer
T.R. Morgan
K.E. Sherman
R. Dretler
D. Fishbein
J.C. Gathe
S. Henn
F. Hinestrosa
C. Huynh
C. McDonald
A. Mills
E.T. Overton
M. Ramgopal
B. Rashbaum
G. Ray
A. Scarsella
J. Yozviak
F. McPhee
Z. Liu
E. Hughes
P.D. Yin
S. Noviello
P. Ackerman
ALLY-2 Investigators

Keywords

Alabama Antiretroviral Antiretroviral Therapy California Colorado Disease Fatigue Florida Genotype genotype 1 HCV Headache Health hepatitis Hepatitis C hepatitis C virus Hiv-1 Human immunology Infection Liver Los Angeles medication Medicine methods Nausea New York NS5A inhibitor NS5B inhibitor Patients Research Safety San Francisco sofosbuvir sustained virologic response Texas therapy treatment Universities Veterans Washington

Type of Article

Journal Article

Test, Evaluate, Monitor
Treatment-Naive
Treatment-Experienced Patients
Unique & Key Populations

Resource Library
About Us
Announcements
Contact Us

Terms of Use
Privacy Policy
Cookies Policy
Accessibility

© 2025 HCV Guidelines All right reserved.

Website by Yoko Co